# Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe

> **NCT07282795** · — · NOT_YET_RECRUITING · sponsor: **Sanofi** · enrollment: 670 (estimated)

## Conditions studied

- Influenza Immunization
- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** Efluelda® Pre-filled syringe

## Key facts

- **NCT ID:** NCT07282795
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2029-02-22
- **Final completion:** 2029-03-20
- **Target enrollment:** 670 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07282795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07282795, "Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07282795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*